| abstract |
Described is the use of one or more fumaric acid monoalkyl esters of formula (I), optionally with admixture of a dialkyl fumarate of formula (II), wherein A is a divalent cation from the series comprising Ca, Mg, Zn or Fe or a monovalent cation from the Li, Na or K and n is the number 1 or 2, depending on the type of cation, and the case of generally used excipients and vehicles for the preparation of a pharmaceutical composition in the form of microtablets or micropellets for the treatment of psoriatic arthritis, neurodermatitis, psoriasis and Crohn's regional enteritis. |